<DOC>
	<DOC>NCT02545452</DOC>
	<brief_summary>To investigate the pharmacokinetic effect of a vaginally administered antimycotic (miconazole), antibiotic (clindamycin), spermicide (nonoxynol-9) or the concomitant use of tampons during the use of an intravaginal ring releasing anastrozole and levonorgestrel</brief_summary>
	<brief_title>Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Nonoxynol</mesh_term>
	<mesh_term>Spermatocidal Agents</mesh_term>
	<criteria>Healthy premenopausal female subject. Age: 18 50 years (inclusive) at the first screening visit. For the subject &gt; 45 years follicle stimulating hormone (FSH) will be investigated at the second screening visit to confirm the premenopausal status (FSH &lt; 40 IU/L in serum). Body mass index (BMI ) above or equal 18, and below or equal 30 kg / mÂ² at the first screening visit. Adequate venous access. Ability to understand and follow studyrelated instructions Agreement to use adequate nonhormonal contraception. Confirmation of the subject's health insurance coverage prior to the first screening examination/visit. Incompletely cured preexisting diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal. Thrombophlebitis, venous / arterial thromboembolic diseases (particularly deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction). Presence or history of prodromata of thrombosis (e.g. transient ischemic attack, angina pectoris). Known hypersensitivity to the study medications (active substances or excipients of the preparations). Regular intake of medication other than hormonal contraceptives. Use of systemic or topical medication or substances which oppose the study objectives or which might influence them within 4 weeks before first administration of the study medication, Smoking of more than 10 cigarettes daily; if the subject is a smoker: subject is older than 35 years Suspicion of or known current drug, medicine or alcohol abuse (including anabolics, highdose vitamins). Abnormal cervical smear Previous ectopic pregnancy.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>